Human Genome Epidemiology Literature Finder
|
Records 1 - 24 (of 24 Records) |
| Query Trace: Anemia and Kras[original query] |
|---|
| Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias. BMC cancer 2010 10 (1): 401. Rocquain Julien, Carbuccia Nadine, Trouplin Virginie, Raynaud Stéphane, Murati Anne, Nezri Meyer, Tadrist Zoulika, Olschwang Sylviane, Vey Norbert, Birnbaum Daniel, Gelsi-Boyer Véronique, Mozziconacci Marie-Joel |
| SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML). Blood 2012 Oct 120 (15): 3080-8. Meggendorfer Manja, Roller Andreas, Haferlach Torsten, Eder Christiane, Dicker Frank, Grossmann Vera, Kohlmann Alexander, Alpermann Tamara, Yoshida Kenichi, Ogawa Seishi, Koeffler H Phillip, Kern Wolfgang, Haferlach Claudia, Schnittger Susan |
| Impact of second-line and later cetuximab-containing therapy and KRAS genotypes in patients with metastatic colorectal cancer: a multicenter study in Japan. Surgery today 2014 Aug 44 (8): 1457-64. Saeki Hiroshi, Emi Yasunori, Kumashiro Ryuichi, Otsu Hajime, Kawano Hiroyuki, Ando Koji, Ida Satoshi, Kimura Yasue, Tokunaga Eriko, Oki Eiji, Morita Masaru, Shimokawa Mototsugu, Maehara Yoshihi |
| Prognostic score including gene mutations in chronic myelomonocytic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 Jul 31 (19): 2428-36. Itzykson Raphaël, Kosmider Olivier, Renneville Aline, Gelsi-Boyer Véronique, Meggendorfer Manja, Morabito Margot, Berthon Céline, Adès Lionel, Fenaux Pierre, Beyne-Rauzy Odile, Vey Norbert, Braun Thorsten, Haferlach Torsten, Dreyfus François, Cross Nicholas C P, Preudhomme Claude, Bernard Olivier A, Fontenay Michaela, Vainchenker William, Schnittger Susanne, Birnbaum Daniel, Droin Nathalie, Solary Er |
| Chronic myelomonocytic leukemia with nucleophosmin (NPM1) mutation. European journal of haematology 2015 Mar . Peng Jie, Zuo Zhuang, Fu Bin, Oki Yasuhiro, Tang Guilin, Goswami Maitrayee, Priyanka Priyanka, Muzzafar Tariq, Medeiros L Jeffrey, Luthra Rajyalakshmi, Wang Sa |
| Effect of RAS status on anti-EGFR monoclonal antibodies + 5-FU infusion-based chemotherapy in first-line treatment of metastatic colorectal cancer: A meta-analysis. Meta gene 2016 Sep 9 110-9. Zhou Mingyi, Yu Ping, Hou Kezuo, Fu Lingyu, Chen Ying, Qu Jinglei, Qu Xiujuan, Liu Yunpeng, Zhang Jingdo |
| Phase II Study of a Non-Platinum-Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung Adenocarcinomas. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Mar . Pietanza Catherine M, Hellmann Matthew D, Fiore John J, Smith-Marrone Stephanie, Basch Ethan M, Schwartz Lawrence H, Ginsberg Michelle S, Shouery Marwan, Newman Samantha K, Shaw Mary, Rogak Lauren J, Lash Alex, Hilden Patrick, Kris Mark |
| Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer. Targeted oncology 2016 Dec . Van Laethem Jean-Luc, Riess Hanno, Jassem Jacek, Haas Michael, Martens Uwe M, Weekes Colin, Peeters Marc, Ross Paul, Bridgewater John, Melichar Bohuslav, Cascinu Stefano, Saramak Piotr, Michl Patrick, Van Brummelen David, Zaniboni Alberto, Schmiegel Wollf, Dueland Svein, Giurescu Marius, Garosi Vittorio L, Roth Katrin, Schulz Anke, Seidel Henrik, Rajagopalan Prabhu, Teufel Michael, Childs Barrett |
| Induction Chemotherapy with Gemcitabine and Cisplatin Followed by Simultaneous Integrated Boost-Intensity Modulated Radiotherapy with Concurrent Gemcitabine for Locally Advanced Unresectable Pancreatic Cancer: Results from a Feasibility Study. Cancer research and treatment 2017 1 49 (4): 1022-1032. Woo Sang Myung, Kim Min Kyeong, Joo Jungnam, Yoon Kyong-Ah, Park Boram, Park Sang-Jae, Han Sung-Sik, Lee Ju Hee, Hong Eun Kyung, Kim Yun-Hee, Moon Hae, Kong Sun-Young, Kim Tae Hyun, Lee Woo J |
| Efficacy and safety of TAS-102 in refractory metastatic colorectal cancer: a meta-analysis. Cancer management and research 2018 10 2915-2924. Chen Duke, Wu Yu-Shen, Lin Huapeng, Wang Yihan, Li Longhao, Zhang T |
| Efficacy of azacitidine is independent of molecular and clinical characteristics - an analysis of 128 patients with myelodysplastic syndromes or acute myeloid leukemia and a review of the literature. Oncotarget 2018 Jun 9 (45): 27882-27894. Kuendgen Andrea, Müller-Thomas Catharina, Lauseker Michael, Haferlach Torsten, Urbaniak Petra, Schroeder Thomas, Brings Carolin, Wulfert Michael, Meggendorfer Manja, Hildebrandt Barbara, Betz Beate, Royer-Pokora Brigitte, Gattermann Norbert, Haas Rainer, Germing Ulrich, Götze Katharina |
| Pediatric-onset Evans syndrome: Heterogeneous presentation and high frequency of monogenic disorders including LRBA and CTLA4 mutations. Clinical immunology (Orlando, Fla.) 2018 1 188 52-57. Besnard Caroline, Levy Eva, Aladjidi Nathalie, Stolzenberg Marie-Claude, Magerus-Chatinet Aude, Alibeu Olivier, Nitschke Patrick, Blanche Stéphane, Hermine Olivier, Jeziorski Eric, Landman-Parker Judith, Leverger Guy, Mahlaoui Nizar, Michel Gérard, Pellier Isabelle, Suarez Felipe, Thuret Isabelle, de Saint-Basile Geneviève, Picard Capucine, Fischer Alain, Neven Bénédicte, Rieux-Laucat Frédéric, Quartier Pierre, |
| Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes. Blood 2019 Apr . Hadjadj Jérôme, Aladjidi Nathalie, Fernandes Helder, Leverger Guy, Magérus-Chatinet Aude, Mazerolles Fabienne, Stolzenberg Marie-Claude, Jacques Sidonie, Picard Capucine, Rosain Jérémie, Fourrage Cécile, Hanein Sylvain, Zarhrate Mohammed, Pasquet Marlène, Abou Chahla Wadih, Barlogis Vincent, Bertrand Yves, Pellier Isabelle, Colomb Bottollier Elodie, Fouyssac Fanny, Blouin Pascale, Thomas Caroline, Cheikh Nathalie, Dore Eric, Pondarre Corinne, Plantaz Dominique, Jeziorski Eric, Millot Frédéric, Garcelon Nicolas, Ducassou Stéphane, Perel Yves, Leblanc Thierry, Neven Bénédicte, Fischer Alain, Rieux-Laucat Frédéric, |
| A phase 1 dose-escalation study of checkpoint kinase 1 (CHK1) inhibitor prexasertib in combination with p38 mitogen-activated protein kinase (p38 MAPK) inhibitor ralimetinib in patients with advanced or metastatic cancer. Investigational new drugs 2019 Nov . Bendell Johanna C, Bischoff Helge G, Hwang Jimmy, Reinhardt Hans Christian, Zander Thomas, Wang Xuejing, Hynes Scott, Pitou Celine, Campbell Robert, Iversen Philip, Farrington Daphne L, Bell-McGuinn Katherine, Thomas Micha |
| Understanding the Prognostic Value of Primary Tumor Location and KRAS in Metastatic Colorectal Cancer: A Post Hoc Analysis of the OPTIMOX3 DREAM Phase III Study. Clinical colorectal cancer 2020 Mar . Chibaudel Benoist, André Thierry, Tournigand Christophe, Louvet Christophe, Benetkiewicz Magdalena, Larsen Annette K, de Gramont Aime |
| Venetoclax plus azacitidine and donor lymphocyte infusion in treating acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation. Annals of hematology 2021 Sep . Zhao Peng, Ni Ming, Ma Dan, Fang Qin, Zhang Yan, Li Yanju, Huang Yi, Chen Ying, Chai Xiao, Zhan Yun, Li Yan, Kang Qian, Zhao Mei, Liu Min, Zhang Fengqi, Huang Shisi, Wen Shuangshuang, Deng Bo, Wang Jis |
| Prediction of survival in patients with advanced, refractory colorectal cancer in treatment with trifluridine/tipiracil: real-world vs clinical trial data. Scientific reports 2021 7 11 (1): 14321. Fernández Montes Ana, Carmona-Bayonas Alberto, Jimenez-Fonseca Paula, Vázquez Rivera Francisca, Martinez Lago Nieves, Covela Rúa Marta, Cousillas Castiñeiras Antía, Gonzalez Villarroel Paula, De la Cámara Gómez Juan, Méndez José Carlos Méndez, Carriles Fernández Carmen, Sanchez Cánovas Manuel, Garcia García Tere |
| KRAS mutations and their associations with clinicopathological features and survival in Vietnamese non?polyp colon cancer patients. Molecular and clinical oncology 2023 7 19 (2): 63. Hoang Minh Cuong, Vu Hong Thang, Bui-Thi Thu Huong, Nguyen Thuan Loi, Nguyen Minh D |
| Phase II study of docetaxel and trametinib in patients with KRAS mutation positive recurrent non-small cell lung cancer (NSCLC) (SWOG S1507, NCT-02642042). Clinical cancer research : an official journal of the American Association for Cancer Research 2023 5 . Shirish M Gadgeel, Jieling Miao, Jonathan W Riess, James Moon, Philip C Mack, Gregory J Gerstner, Timothy F Burns, Asma Taj, Wallace L Akerley, Konstantin H Dragnev, Noel Laudi, Mary W Redman, Jhanelle E Gray, David R Gandara, Karen Kel |
| The enrichment of Fanconi anemia/homologous recombination pathway aberrations in ATM/ATR-mutated NSCLC was accompanied by unique molecular features and poor prognosis. Journal of translational medicine 2023 12 21 (1): 874. Wei Wei, Fangfang Shi, Yang Xu, Yang Jiao, Ying Zhang, Qiuxiang Ou, Xue Wu, Lingyi Yang, Jinhuo L |
| Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia. Leukemia 2023 10 . Jan-Niklas Eckardt, Sebastian Stasik, Christoph Röllig, Andreas Petzold, Tim Sauer, Sebastian Scholl, Andreas Hochhaus, Martina Crysandt, Tim H Brümmendorf, Ralph Naumann, Björn Steffen, Volker Kunzmann, Hermann Einsele, Markus Schaich, Andreas Burchert, Andreas Neubauer, Kerstin Schäfer-Eckart, Christoph Schliemann, Stefan W Krause, Regina Herbst, Mathias Hänel, Maher Hanoun, Ulrich Kaiser, Martin Kaufmann, Zdenek Rácil, Jiri Mayer, Uta Oelschlägel, Wolfgang E Berdel, Gerhard Ehninger, Hubert Serve, Carsten Müller-Tidow, Uwe Platzbecker, Claudia D Baldus, Andreas Dahl, Johannes Schetelig, Martin Bornhäuser, Jan Moritz Middeke, Christian Thie |
| Molecular characteristics of patients with colorectal signet-ring cell carcinoma with different ABO blood groups. Heliyon 2024 8 10 (13): e34220. Wan-Ning Zhang, Wei-Jie Liang, Ying Zhang, Ming-Jian Liang, Ming-Juan Zhang, Qi Chen, Zhou-Pei Mo, Mei-Yi Wu, Xue-Zi Weng, Rui Han, Yong-Neng Liang, Miao-La Ke, Wen-Qian L |
| Potent covalent irreversible inhibitor of KRAS G12C IBI351 in patients with advanced solid tumors: First-in-human phase I study. European journal of cancer (Oxford, England : 1990) 2024 10 212 114337. Qing Zhou, Nong Yang, Mingfang Zhao, Dingzhi Huang, Jun Zhao, Yan Yu, Ying Yuan, Longhua Sun, Xiaorong Dong, Tongmei Zhang, Qian Chu, Xingya Li, Xiangjiao Meng, Huijuan Wang, Xiang Wang, Dongde Wu, Sheng Hu, Jinlu Shan, Lian Liu, Meili Sun, Zhiye Zhang, Haibo Zhu, Jingjing Huang, Mengna Huang, Lingge Cheng, Sujie Zhang, Hui Zhou, Yi-Long |
| TAS-102 (trifluridine/tipiracil) plus bevacizumab versus TAS-102 alone as salvage treatment options for metastatic colorectal cancer in routine clinical practice. Frontiers in oncology 2024 10 14 1450732. Ji Eun Shin, Sung Hee Lim, Jeeyun Lee, Ho Yeong Lim, Young Suk Park, Seung Tae K |
- Page last reviewed:Feb 1, 2024
- Content source: